statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	573
SG - Singapore	173
IT - Italia	76
CN - Cina	73
SE - Svezia	64
IE - Irlanda	60
IN - India	60
BR - Brasile	48
HK - Hong Kong	35
VN - Vietnam	29
DE - Germania	24
GB - Regno Unito	23
PT - Portogallo	19
AU - Australia	18
AT - Austria	17
FR - Francia	17
TR - Turchia	16
RU - Federazione Russa	15
BE - Belgio	12
MY - Malesia	12
TH - Thailandia	12
CA - Canada	10
JP - Giappone	9
IR - Iran	7
NL - Olanda	7
KR - Corea	6
TW - Taiwan	6
UA - Ucraina	6
ES - Italia	5
ID - Indonesia	5
PK - Pakistan	5
PL - Polonia	5
MX - Messico	4
ZA - Sudafrica	4
CH - Svizzera	3
CZ - Repubblica Ceca	3
FI - Finlandia	3
AR - Argentina	2
CO - Colombia	2
EG - Egitto	2
KZ - Kazakistan	2
NZ - Nuova Zelanda	2
PA - Panama	2
PH - Filippine	2
SK - Slovacchia (Repubblica Slovacca)	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AQ - Antartide	1
BD - Bangladesh	1
BG - Bulgaria	1
CL - Cile	1
DK - Danimarca	1
DZ - Algeria	1
EC - Ecuador	1
EE - Estonia	1
GT - Guatemala	1
HR - Croazia	1
LK - Sri Lanka	1
LT - Lituania	1
MD - Moldavia	1
NG - Nigeria	1
OM - Oman	1
RO - Romania	1
UZ - Uzbekistan	1
Totale	1.500

Nome	#
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry	398
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise	124
Re-ricoveri a 30 giorni in pazienti ospedalizzati per frattura d’anca: analisi retrospettiva dei dati SDO della regione Abruzzo	115
Exploring the concept of vigor and dys-vigor in men of 50-65 years: effects of Robuvit®	106
Management of symptoms, pain and mobility with supplementary managements (including Movardol Forte) in osteoarthrosis: A 6-month, morphology supplement study	105
Supplementation with a new food grade delivery system of Boswellia and Centella in the intervertebral discs registry: The Sager study	105
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment.	104
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth	90
Chronic venous insufficiency and venous microangiopathy: Management with compression and Pycnogenol®	88
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study	87
Central Cardiovascular Calcifications: Supplementation With Pycnogenol® and Centellicum®: Variations Over 12 Months	82
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study.	78
A sport cream (Harpago-Boswellia-ginger-escin) for localized neck/shoulder pain	76
Totale	1.558

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	35	0	0	0	0	0	14	0	1	5	0	9	6
2021/2022	88	0	7	1	20	11	1	2	3	5	0	8	30
2022/2023	252	24	41	20	28	20	43	10	25	19	1	18	3
2023/2024	209	9	5	15	0	19	34	25	11	16	22	23	30
2024/2025	527	36	89	73	20	29	50	14	37	44	33	45	57
2025/2026	342	57	30	51	88	106	10	0	0	0	0	0	0
Totale													1.558